Introduction
Increasing demands for quality assurance in medicine—by patients, relatives, insurance companies, and authorities all over the world—have stimulated the development of a wide range of registries and other tools to answer those needs. As early as in 1978, the board of directors of the German Society for Thoracic and Cardiovascular Surgery (www.dgthg.de) decided to set up an annually updated database of all cardiac surgical procedures in terms of a voluntary registry. Since 1989, the updated data of the registry are published annually.[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22] The aim of this registry continues to illustrate developments and trends in cardiac surgery in Germany and it enables each participating cardiac surgical unit to compare its own results with the nationwide achievements.
For monitoring actual conditions as well as the development in cardiac medicine, the registry includes particular techniques such as off-pump cardiac surgery or minimal invasive mitral valve operations and also innovative technologies such as transapical or transvascular aortic valve implantation (TAVI) (see [Table V3]). Thereby important findings for present patient safety and the future of patient care may be collected and evaluated.
The data presented in this report comprehend assorted data of the year 2012.
Materials and Methods
Since 2004, a standardized questionnaire gathers detailed information about each individual procedure exactly defined by a German adaption of the International Classification of Procedures in Medicine called operation code (Operationen- und Prozedurenschlüssel).
All participants were requested to complete the structured questionnaire until January 21, 2013, asking for all performed procedures and associated in-hospital mortality. The completed questionnaire had to be sent to the office of the GSTCVS, where they were evaluated for completeness and compiled for further analysis, thus ensuring anonymity for each individual institution. This compilation algorithm guarantees a high compliance for submission of complete datasets.
Inclusion criteria for the registry 2012 were all patients receiving cardiac surgical procedures performed between January 1, 2012, and December 31, 2012, unrelated to the dates of admission or discharge as compared with other registries. Alike to all previous years, the number of procedures was counted rather than individual patients. For example, if a patient required additional coronary artery bypass grafting (CABG) due to a complication after initial aortic valve replacement during one admission, one count in the category “aortic valve replacement” and another in the category “coronary surgery” are enumerated. Thus, the registry contains more procedures than the real number of patients operated on.
Death of patients was defined as in-hospital mortality. As per the definition, the observed mortality is always attributed to the first cardiac procedure, for example, the death of a patient requiring CABG due to a complication of an aortic valve procedure would only be attributed to the aortic valve procedure.
The main reason for this structural setup of the registry—established over several decades—is to keep the German data privacy act with its specific regulations for patients. Furthermore, it seemed to be relevant getting detailed information about all performed procedures and not only the number of treated patients. Last but not the least, the process of data acquisition had to be simplified for all cardiac surgery units in Germany thus enabling the submission of a complete dataset, regardless of the locally existing hard- and software used for data management.
In 2012, a total of 79 institutions performed heart surgery. Fortunately, all units answered the questionnaire and delivered a complete dataset for the year 2012 including hospital mortality rates.
Registry Data 2012
[Table 1] illustrates the development of procedures using extracorporeal circulation (ECC) over more than two decades in Germany. The number of heart operations using ECC remains on a stable level.
Table 1
Frequency of open heart procedures in Germany from 2003 to 2012
Year
|
2003
|
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
Total number of units
|
78
|
79
|
79
|
80
|
80
|
79
|
80
|
79
|
78
|
79
|
Total number of operations
|
94,712
|
96,340
|
91,967
|
91,057
|
91,618
|
89,773
|
86,916
|
84,686
|
84,402
|
84,388
|
Average per unit
|
1,214
|
1,219
|
1,164
|
1,138
|
1,145
|
1,136
|
1,086
|
1,072
|
1,082
|
1,068
|
Overall, 177,694 procedures were reported to the registry for the year 2012, an increase of 2.5% (2011: 173,347 procedures). A total of 101,887 cardiac surgical procedures (excluded: implantable cardioverter defibrillator (ICD), pacemakers, and miscellaneous procedures without ECC) display an increase of 1.57% (n = 1,596) compared with the year 2011 (100,291 procedures) ([Table 2]). [Tables 3]
[4]
[5] to [6], [Tables V1]
[V2]
[V3]
[V4]
[V5]
[V6] to [V7], [Tables C1]
[C2] to [C3], [Tables Con1] and [Con2], [Tables Mis1]
[Mis2]
[Mis3]
[Mis4] to [Mis5], and [Figs. 1]
[2]
[3]
[4]
[5]
[6]
[7]
[8] to [9] demonstrate the compiled registry data of 2012 for various categories.
Fig. 1 (A) Cardiac surgery in Germany from 2003 to 2012. (1) CABG and combinations: all types of isolated coronary surgery with or without ECC and any combined procedure. (2) Valve procedures: all types of isolated heart valve surgery; heart valve procedures in combination with aortic surgery are summarized in the miscellaneous group. (3) Congenital heart surgery: all procedures with or without ECC; atrial septal defect repair in adults in combination with CABG or heart valve surgery are summarized in the CABG or heart valve surgery group. (4) Miscellaneous procedures: all other types of procedures with ECC. (B) Development of cardiac surgery in Germany during the past 10 years. CABG, coronary artery bypass grafting; ECC, extracorporeal circulation.
Fig. 2 Development of mortality for selected procedures.
Fig. 3 Isolated CABG: the number of CABG declined since the year 2003 while the percentage of off-pump procedures slightly increased. CABG, coronary artery bypass grafting.
Fig. 4 Isolated aortic valve replacement from 2003 to 2012 in Germany. The use of xenografts continuously increased while the aortic valve replacement using mechanical prostheses decreased. The sustained difference in mortality seems to be related to the difference in age pattern. Ross, homograft procedures, and TAVI are excluded in this overview. TAVI, transcatheter aortic valve implantation.
Fig. 5 Surgical aortic valve replacement or TAVI. The figure shows an obvious increase of TAVI. In 2012, 35.5% of isolated aortic valve procedures were performed by endovascular or transapical implantation. TAVI, transcatheter aortic valve implantation.
Fig. 6 Age distribution of cardiac procedures (ICD and pacemaker procedures excluded) since 2003. Currently, 53.7% of the patients are at least 70 years. Patients younger than 20 years are excluded.
Fig. 7 Distribution of urgency 2003 and 2012.
Fig. 8 Isolated mitral valve surgery over the past 10 years. In 64.4% MV reconstructions and in 35.6% MV replacements were performed. In 1994, the rate of reconstruction just reached 21%.
Fig. 9 Age distribution of patients undergoing congenital heart surgery in Germany over the past 10 years. No relevant changes can be observed. However, there may be a bias since not all relevant procedures can be allocated exactly to the congenital heart disease group in patients older than 18 years (e.g., aortic valve disease).
Table 2
Results of all 79 units performing cardiac surgery in 2012
Category
|
With ECC
|
Without ECC
|
Total
|
% change
|
Valve procedures
|
21,918
|
6,603
|
28,521
|
+ 5.7%
|
Coronary surgery
|
48,443
|
6,859
|
55,302
|
+ 0.0%
|
Congenital heart surgery
|
4,651
|
942
|
5,593
|
− 0.1%
|
Surgery of thoracic aorta
|
6,805
|
575
|
7,380
|
+ 2.5%
|
Other cardiac surgery
|
1,276
|
1,197
|
2,473
|
− 6.0%
|
Assist devices
|
812
|
1,806
|
2,618
|
+ 24.1%
|
Pacemaker and ICD
|
93
|
25,139
|
25,232
|
− 3.0%
|
Extracardiac surgery
|
390
|
50,185
|
50,575
|
+ 6.4%
|
Total
|
84,388
|
93,306
|
177,694
|
+ 2.5%
|
Abbreviation: ECC, extracorporeal circulation.
Note: The percentage indicates changes compared with 2011.
Table 3
Distribution of individual units according to the number of cardiac surgery procedures with or without ECC
Number of operations
|
<500
|
500–999
|
1,000–1,499
|
1,500–1,999
|
2,000–5,000
|
Number of units
|
6
|
24
|
26
|
13
|
10
|
Average per unit
|
378
|
803
|
1,186
|
1,706
|
2,781
|
Min–max
|
271–474
|
538–990
|
1,019–1,468
|
1,517–1,959
|
2,169–3,814
|
Abbreviation: ECC, extracorporeal circulation.
Note: One unit only performs operations in patients with congenital heart disease.
Table 4
Distribution of units according to surgical profiles in 2012
Procedures
|
Number of units
|
Coronary surgery
|
78
|
Valve surgery
|
78
|
Congenital heart surgery under use of ECC in children < 1 y
|
24[a]
|
Heart transplantation
|
22[b]
|
Heart–lung transplantation
|
4
|
Abbreviation: ECC, extracorporeal circulation.
a Surgery for congenital heart disease with ECC in children < 1 year (n = 2,024); thereof: 1–19 operations in 3 units, 21–45 operations in 7 units, 50–90 operations in 6 units, and 109–269 operations in 8 units.
b Heart transplantations (HTx) (n = 327): 64% of the HTx in 2012 were performed by 6 units with ≥15 HTx per year; thereof: 1–4 transplantations in 4 units, 5–7 transplantations in 6 units, 10–14 transplantations in 6 units, and 21–73 transplantations in 6 units.
Table 5
Additional demographic data for procedures with ECC in 2012 and 2011
|
2012
|
2011
|
Emergency operations
|
11,878
|
11.6%
|
11,911
|
11.9%
|
Redo procedures
|
8,424
|
8.2%
|
8,511
|
8.5%
|
Age > 69 y
|
97,572
|
53.7%
|
95,456
|
53.6%
|
Abbreviation: ECC, extracorporeal circulation.
Note: The numbers in each category reflect procedures and not individual patients.
Table 6
Gender distribution
Male/female ratio among cardiac procedures
|
Valve procedures
|
56%
|
44%
|
Coronary surgery
|
76%
|
24%
|
Congenital heart surgery
|
53%
|
47%
|
Surgery of thoracic aorta
|
69%
|
31%
|
Other cardiac surgery
|
52%
|
48%
|
Assist devices
|
77%
|
23%
|
Pacemaker and ICD
|
65%
|
35%
|
Extracardiac surgery
|
63%
|
37%
|
Total
|
66%
|
34%
|
Note: Coronary surgery (48,443 on-pump and 6,859 off-pump procedures) and all congenital heart surgery procedures are included in this table.
Table V1
Isolated heart valve procedures
Procedures
|
n
|
Deaths
|
%
|
Single
|
18,094
|
624
|
3.4
|
Double
|
3,133
|
289
|
9.2
|
Triple
|
400
|
52
|
13.0
|
Single, transcatheter access
|
6,795
|
382
|
5.6
|
Double, transcatheter access
|
9
|
2
|
22.2
|
Not specified
|
90
|
7
|
7.8
|
Total
|
28,521
|
1,356
|
4.8
|
Notes: Combined procedures (with CABG, aortic surgery) are excluded. Transcatheter procedures: 6,479 aortic valve implantations; 42 mitral valve implantations; 269 mitral valve repairs, 5 tricuspidal valve repairs, 9 double aortic and mitral valve procedures, and no pulmonary valve implantation.
Table V2
Access type in single valve procedures
Position
|
n
|
Deaths
|
%
|
Aortic sternotomy
|
9,738
|
314
|
3.2
|
Aortic partial sternotomy
|
2,168
|
36
|
1.7
|
Aortic transvascular
|
3,550
|
167
|
4.7
|
Aortic transapical
|
2,929
|
210
|
7.2
|
Mitral sternotomy
|
3,110
|
186
|
6.0
|
Mitral miscellaneous
|
2,512
|
42
|
1.7
|
Mitral transcatheter
|
311
|
4
|
1.3
|
Tricuspid sternotomy
|
407
|
36
|
8.8
|
Tricuspid miscellaneous
|
109
|
7
|
6.4
|
Tricuspid transcatheter
|
5
|
1
|
20.0
|
Pulmonary sternotomy
|
50
|
3
|
6.0
|
Pulmonary miscellaneous
|
0
|
–
|
–
|
Pulmonary transcatheter
|
0
|
0
|
–
|
Total
|
24,889
|
1,006
|
4.0
|
Notes: A total of 2,512 (45%) mitral valve procedures were performed by a minimally invasive access. The number of isolated aortic valve procedures by sternotomy increased from 11,668 procedures in 2011 to 11,906 in 2012.
Table V3
Isolated aortic valve procedures
Type
|
n
|
Deaths
|
%
|
Mechanical prosthesis
|
1652
|
37
|
2.2
|
Xenograft
|
10091
|
308
|
3.1
|
Homograft
|
36
|
4
|
11.1
|
Reconstruction
|
127
|
1
|
0.8
|
Total
|
11906
|
350
|
2.9
|
Notes: Of 11,906 procedures, 2168 (18%) were performed via partial sternotomy. Transcatheter procedures were not included.
Table V4
Isolated mitral valve procedures
Type
|
n
|
Deaths
|
%
|
Mechanical prosthesis
|
570
|
38
|
6.7
|
Xenograft
|
1,425
|
131
|
9.2
|
Homograft
|
6
|
0
|
0.0
|
Reconstruction
|
3,621
|
59
|
1.6
|
Total
|
5,622
|
228
|
4.1
|
Notes: Of 5,622 procedures, 2,512 (45%) were performed via minimally invasive access. Transcatheter procedures were excluded.
Table V5
Multiple heart valve procedures
Combination
|
n
|
Deaths
|
%
|
Aortic + mitral
|
1,345
|
165
|
12.3
|
Mitral + tricuspid
|
1,489
|
103
|
6.9
|
Aortic + tricuspid
|
185
|
18
|
9.7
|
Tricuspid + pulmonary
|
16
|
1
|
6.3
|
Aortic + pulmonary[a]
|
98
|
2
|
2.0
|
Aortic + mitral + tricuspid
|
399
|
52
|
13.0
|
Aortic + mitral + pulmonary
|
1
|
0
|
0.0
|
Total
|
3,533
|
341
|
9.7
|
Note: Transcatheter procedures were excluded.
a Including Ross procedures.
Table V6
Mitral valve surgery—implantation resp. replacement versus reconstruction
Mitral valve surgery
|
n
|
Total deaths
|
% death
|
% reconstruction
|
Replacement
|
% death
|
Reconstruction
|
% death
|
n
|
Deaths
|
n
|
Deaths
|
Isolated
|
5,622
|
228
|
4.1
|
64.4
|
2,001
|
169
|
8.4
|
3,621
|
59
|
1.6
|
Mitral valve +
|
|
|
|
|
|
|
|
|
|
|
Aortic valve
|
1,345
|
165
|
12.3
|
42.5
|
773
|
115
|
14.9
|
572
|
50
|
8.7
|
Tricuspid valve reconstruction[a]
|
1,445
|
99
|
6.9
|
65.3
|
501
|
54
|
10.8
|
944
|
45
|
4.8
|
CABG
|
2,640
|
252
|
9.5
|
70.2
|
786
|
129
|
16.4
|
1,854
|
123
|
6.6
|
CABG + aortic valve replacement
|
674
|
119
|
17.7
|
53.1
|
316
|
68
|
21.5
|
358
|
51
|
14.2
|
Total
|
11,726
|
863
|
7.4
|
62.7
|
4,377
|
535
|
12.2
|
7,349
|
328
|
4.5
|
Abbreviation: CABG, coronary artery bypass grafting.
a Forty-four procedures (not specified mitral valve + tricuspid valve surgery) were excluded. Deaths: 9.1% (4/44).
Table V7
Transcatheter valve procedures: 45.2% of TAVI were performed by transapical access
|
Total
|
Deaths
|
Death %
|
With ECC
|
Without ECC
|
n
|
Deaths
|
n
|
Deaths
|
Aortic valve implantation
|
6,479
|
377
|
5.8
|
182
|
62
|
6,297
|
315
|
Transvascular access[a]
|
3,550
|
167
|
4.7
|
80
|
24
|
3,470
|
143
|
Transapical access
|
2,929
|
210
|
7.2
|
102
|
38
|
2,827
|
172
|
Mitral valve
|
311
|
4
|
1.3
|
16
|
1
|
295
|
3
|
Repair
|
269
|
4
|
1.5
|
11
|
1
|
258
|
3
|
Implantation[b]
|
42
|
0
|
0.0
|
5
|
0
|
37
|
0
|
Tricuspid valve repair
|
5
|
1
|
20.0
|
2
|
0
|
3
|
1
|
Aortic + mitral valve implantation
|
9
|
2
|
22.2
|
1
|
0
|
8
|
2
|
Aortic valve implantation[b] + CABG
|
23
|
5
|
21.7
|
3
|
2
|
20
|
3
|
Total
|
6,827
|
389
|
5.7
|
204
|
65
|
6,623
|
324
|
Abbreviations: CABG, coronary artery bypass grafting; ECC, extracorporeal circulation; TAVI, transapical or transvascular aortic valve implantation.
Notes: Pulmonary valve implantation for congenital heart disease are excluded, no procedure was reported for adults without congenital lesion. 2.8% of TAVI procedures were performed under use of ECC. It has to be assumed that ECC was mostly used in emergency situations, which explains the mortality of 34.1% in this group. Nevertheless, this underlines the necessity of a cardiac surgery on-site for TAVI procedures.
a Femoral, subclavian, or transaortic access.
b Transvascular and transapical access.
Table C1
Isolated CABG with ECC and combined procedures with ECC
Procedures
|
n
|
Deaths
|
%
|
CABG
|
42,060
|
1,217
|
2.9
|
CABG +
|
Transmyocardial laser revascularization
|
6
|
0
|
0.0
|
Left ventricular-aneurysm resection
|
168
|
11
|
6.5
|
Aortic valve replacement
|
8,216
|
432
|
5.3
|
Transcatheter aortic valve implantation
|
23
|
5
|
21.7
|
Mitral valve replacement
|
786
|
129
|
16.4
|
Mitral valve repair
|
1,854
|
123
|
6.6
|
Aortic + mitral valve replacement
|
316
|
68
|
21.5
|
Aortic valve replacement + mitral valve repair
|
358
|
51
|
14.2
|
Other
|
1,515
|
95
|
6.3
|
Total
|
55,302
|
2,131
|
3.9
|
Abbreviations: CABG, coronary artery bypass grafting; ECC, extracorporeal circulation.
Table C2
Isolated CABG with ECC
Number of grafts
|
N
|
Deaths
|
%
|
Single
|
1,213
|
73
|
6.0
|
Double
|
7,399
|
250
|
3.4
|
Triple
|
15,667
|
466
|
3.0
|
Quadruple
|
8,734
|
242
|
2.8
|
Quintuple + more
|
2,560
|
57
|
2.2
|
Total
|
35,573
|
1,088
|
3.1
|
Abbreviations: CABG, coronary artery bypass grafting; ECC, extracorporeal circulation.
Table C3
Isolated CABG off-pump
Number of grafts
|
n
|
Deaths
|
%
|
Single
|
1,525
|
33
|
2.2
|
Double
|
1,938
|
45
|
2.3
|
Triple
|
2,132
|
40
|
1.9
|
Quadruple
|
750
|
10
|
1.3
|
Quintuple + more
|
142
|
1
|
0.7
|
Total
|
6,487
|
129
|
2.0
|
Abbreviation: CABG, coronary artery bypass grafting.
Table Con1
Patient's age distribution for congenital heart surgery
Age
|
n
|
Deaths
|
%
|
(A) Without ECC
|
Older than 18 y
|
34
|
1
|
2.9
|
1–17 y
|
142
|
0
|
0.0
|
Younger than 1 y
|
766
|
20
|
2.6
|
Total A
|
942
|
21
|
2.2
|
(B) With ECC
|
Older than 18 y
|
989
|
23
|
2.3
|
1–17 y
|
1,638
|
16
|
1.0
|
Younger than 1 y
|
2,024
|
79
|
3.9
|
Total B
|
4,651
|
118
|
2.5
|
Abbreviation: ECC, extracorporeal circulation.
Table Con2
Congenital heart surgery with and without ECC
Lesion/procedure
|
Age < 1 y
|
Age 1–17 y
|
Age ≥ 18 y
|
n
|
Deaths
|
%
|
n
|
Deaths
|
%
|
n
|
Deaths
|
%
|
ASD
|
51
|
0
|
0.0
|
254
|
0
|
0.0
|
287
|
6
|
2.1
|
Complete AV canal
|
174
|
5
|
2.9
|
62
|
0
|
0.0
|
11
|
0
|
0.0
|
VSD
|
326
|
3
|
0.9
|
112
|
1
|
0.9
|
21
|
0
|
0.0
|
Fallot tetralogy
|
177
|
5
|
2.8
|
45
|
0
|
0.0
|
9
|
0
|
0.0
|
DORV
|
44
|
2
|
4.5
|
12
|
0
|
0.0
|
2
|
0
|
0.0
|
TGA
|
159
|
4
|
2.5
|
3
|
0
|
0.0
|
1
|
0
|
0.0
|
TGA + VSD
|
65
|
0
|
0.0
|
8
|
1
|
12.5
|
0
|
0
|
–
|
Truncus arteriosus
|
31
|
2
|
6.5
|
5
|
0
|
0.0
|
1
|
0
|
0.0
|
Fontan
|
5
|
0
|
0.0
|
231
|
5
|
2.2
|
10
|
2
|
20.0
|
Norwood
|
187
|
26
|
13.9
|
2
|
0
|
0.0
|
0
|
0
|
–
|
Pulmonary valve
|
48
|
0
|
0.0
|
225
|
4
|
1.8
|
82
|
0
|
0.0
|
Transcatheter pulmonary valve implantation
|
1
|
0
|
0.0
|
6
|
0
|
0.0
|
9
|
1
|
11.1
|
Aortic valve
|
61
|
0
|
0.0
|
209
|
1
|
0.5
|
319
|
7
|
2.2
|
Ross procedure
|
10
|
1
|
10.0
|
26
|
0
|
0.0
|
29
|
0
|
0.0
|
Mitral valve
|
43
|
1
|
2.3
|
93
|
1
|
1.1
|
69
|
5
|
7.2
|
Tricuspid valve
|
44
|
2
|
4.5
|
51
|
0
|
0.0
|
44
|
1
|
2.3
|
PDA
|
286
|
9
|
3.1
|
14
|
0
|
0.0
|
3
|
0
|
0.0
|
Coarctation
|
195
|
1
|
0.5
|
44
|
0
|
0.0
|
6
|
0
|
0.0
|
Transplantation heart
|
6
|
0
|
0.0
|
17
|
1
|
5.9
|
0
|
0
|
−
|
Transplantation heart + lung
|
0
|
0
|
−
|
1
|
0
|
0.0
|
0
|
0
|
−
|
Transplantation lung
|
0
|
0
|
−
|
9
|
1
|
11.1
|
0
|
0
|
−
|
Others
|
877
|
53
|
6.0
|
351
|
24
|
6.8
|
120
|
3
|
2.5
|
Total
|
2,790
|
114
|
4.1
|
1,780
|
39
|
2.2
|
1,023
|
25
|
2.4
|
Abbreviations: ASD, atrial septal defect; AV, atrioventricular; DORV, double outlet right ventricle; PDA, patent ductus arteriosus; TGA, transposition at the great arteries; VSD, ventricular septal defect.
Table Mis1
Development of Ross procedures in various age groups
Autologous aortic valve replacement (Ross procedure)
|
2002
|
2005
|
2008
|
2009
|
2010
|
2011
|
2012
|
n
|
n
|
n
|
n
|
n
|
n
|
n
|
Patients ≥ 18 y
|
163
|
235
|
207
|
175
|
184
|
134
|
117
|
Patients < 18 y
|
61
|
46
|
42
|
54
|
43
|
40
|
36
|
Total
|
224
|
281
|
249
|
229
|
227
|
174
|
153
|
Table Mis2
Transplantation all pediatric transplantations (demonstrated in Table Con3) are included in this table
Transplantation
|
With ECC
|
Without ECC
|
n
|
Deaths
|
%
|
n
|
Deaths
|
%
|
Heart
|
327
|
38
|
11.6
|
|
|
|
Heart + lung
|
14
|
1
|
7.1
|
|
|
|
Lung
|
71
|
4
|
5.6
|
244
|
11
|
4.5
|
Notes: Eurotransplant (ET) reported for the same period 341 heart transplantations (HTx), 13 heart + kidney transplantations, 2 heart + liver transplantations, 10 heart–lung transplantations, 268 double lung, 57 single lung transplantations, 1 lung + kidney transplantations, and 1 lung + liver transplantations. The differences (ET: − 28 LTx, − 5 HTx) may be explained by different inclusion criteria (time of transplantation) for the registry and the ET database.
Table Mis3
Aortic surgery
Aortic surgery[a]
|
With ECC
|
Without ECC
|
n
|
Deaths
|
%
|
n
|
Deaths
|
%
|
Supracoronary ascending
|
1,623
|
110
|
6.8
|
|
|
|
Infracoronary ascending
|
|
|
–
|
|
|
|
Mechanical valve conduits
|
510
|
36
|
7.1
|
|
|
|
Biological valve conduits
|
806
|
79
|
9.8
|
|
|
|
David technique
|
463
|
10
|
2.2
|
|
|
|
Yacoub technique
|
119
|
4
|
3.4
|
|
|
|
Other
|
263
|
27
|
10.3
|
|
|
|
Supracoronary ascending + aortic valve replacement
|
1,363
|
66
|
4.8
|
|
|
|
Aortic arch replacement[b]
|
1,472
|
194
|
13.2
|
|
|
|
Descending
|
90
|
6
|
6.7
|
14
|
3
|
21.4
|
Thoracoabdominal
|
89
|
7
|
7.9
|
59
|
7
|
11.9
|
Endovascular stent, descending
|
7
|
0
|
0.0
|
502
|
24
|
4.8
|
Total
|
6,805
|
539
|
7.9
|
575
|
34
|
5.9
|
Notes: All procedures involving aortic surgery are included. Isolated aortic surgery as well as all possible combined procedures (e.g., additional CABG) are summarized in this category.
a Procedures for abdominal aortic diseases are not included: 486 abdominal and 488 endovascular stents, abdominal.
b All possible combined procedures are included in this category; the only common denominator is aortic arch surgery.
Table Mis4
Pacemaker and ICD procedures
Pacemaker and ICD
|
Total
|
Deaths
|
Death %
|
With ECC
|
Without ECC
|
n
|
Deaths
|
n
|
Deaths
|
Pacemaker: implantation
|
9,276
|
54
|
0.6
|
17
|
2
|
9,259
|
52
|
Pacemaker: exchange
|
1,976
|
5
|
0.3
|
0
|
0
|
1,976
|
5
|
Pacemaker: revision
|
2,966
|
38
|
1.3
|
42
|
4
|
2,924
|
34
|
ICD: implantation
|
4,963
|
12
|
0.2
|
1
|
0
|
4,962
|
12
|
ICD: exchange
|
1,812
|
1
|
0.1
|
0
|
0
|
1,812
|
1
|
ICD: revision
|
3,228
|
44
|
1.4
|
29
|
0
|
3,199
|
44
|
Miscellaneous
|
1,011
|
6
|
0.6
|
4
|
0
|
1,007
|
6
|
Total
|
25,232
|
160
|
0.6
|
93
|
6
|
25,139
|
154
|
Table Mis5
Surgical ablation procedures
Energy
|
Total
|
Endocardiac ablation, n
|
Total, n
|
Unipolar radiofrequency
|
198
|
159
|
39
|
Unipolar cryoradiofrequency
|
469
|
272
|
197
|
Bipolar radiofrequency
|
1,967
|
263
|
1,704
|
Cryothermy
|
1,706
|
1,439
|
267
|
Microwave
|
38
|
22
|
16
|
Focused ultrasound
|
688
|
71
|
617
|
Laser
|
1
|
0
|
1
|
other
|
11
|
2
|
9
|
Total
|
5,078
|
2,228
|
2,850
|
Notes: All isolated ablation procedures and all possible combination of procedures (e.g., CABG + ablation) are included. Total of n = 319 procedures are not specified with regard to endocardiac/epicardiac ablation.
Compared with the data of previous years, several important developments continue unchanged in 2012. Over nearly two decades, the distribution of patient age ([Fig. 6]) showed a shift to older patients with presently 53.7% of the cardiac procedures performed in patients of at least 70 years of age and 13.8% in patients of 80 years or older. However, mortality remained on the same low level or even decreased slightly over the represented decades (see [Fig. 1B]). The rate of CABG procedures decreased over the past years while the relative number of off-pump CABG showed a slight increase to 15.4% (2011: 14.7%) ([Fig. 3]).
Since 2004 more than 50% of isolated mitral valve procedures are reconstructions, in 2012 mitral valve reconstruction could be achieved in 64.4% of the procedures ([Fig. 8]). On the basis of the fact that all isolated mitral valve procedures are included, regardless of the underlying disease, valve morphology, or urgency of operation, it has to be assumed that the relative rate of mitral valve reconstruction would certainly be even higher if patients without possibility or indication for reconstruction would have been excluded (e.g., mitral valve stenosis, calcifications, or endocarditis). In other publications, for example Gammie et al,[23] patients with mitral valve stenosis, endocarditis, and emergency procedures were excluded, so the reconstruction rate must be interpreted with caution compared to this registry.
The continued increase of left ventricular assist device implantation ([Fig. 10]) emphasizes the increasing relevance of mechanical circulatory support.
Fig. 10 Development of mechanical circulatory support in Germany over the past 9 years. There is a significant increase in implantations of left ventricular assist devices (LVAD). However, in 2012, the number of implanted paracorporeal biventricular support systems (BVAD) was only 66% compared with the previous years. The number of total artificial heart (TAH) implantations remained on a low level.
Again the most remarkable trend is the repeated extensive increase of TAVI procedures ([Fig. 5]), although the number of isolated aortic valve replacement procedures remained on a stable level. Starting in 2006 with just 78 implantations (0.67% of isolated aortic valve procedures), in 2012 a total of 6,479 (35.5%) TAVI were reported to the registry in 2012. It must be emphasized that the 79 institutions which contribute their data to this registry do not represent all departments performing TAVI in Germany. In addition, there are some institutions performing TAVI via transvascular access without a cardiac surgery on-site. This proceeding is not in accordance with the recommendations of the European guideline on the management of valvular heart disease version 2012.[24]
In this context, the short-, mid-, and long-term results of the German Aortic Valve Registry and the annual findings of the legal quality assurance (§137 SGB V), conducted by the AQUA Institute, are of outstanding patient benefit.
Discussion
The registry of the GSTCVS enables a comprehensive overview of all cardiac surgical procedures performed in Germany in 2012. The accuracy of this registry is considered to be high due to the implemented compilation algorithm using operation codes. This is supported by other authors who could demonstrate a high accuracy for major outcome parameters in unaudited registries.[25] In continuation to previous years, it can be concluded that cardiac surgery in Germany is performed on a constantly high level with a low in-hospital mortality compared with other international registries. This conclusion is especially important in an era of demographic change of the German population resulting in a continuously increasing patient age and related comorbidities, both leading to a higher preoperative risk profile.
Compared with 2011, the number of cardiac surgery procedures nearly remains on the same level due to the still increasing number of catheter-based valve procedures.
Further improvements in the basic configuration of the registry are necessary to allow a more detailed and particularly a risk-adjusted analysis of the data. However, if significant structural changes of data collection for the registry are conducted, it must be ensured that data compatibility still allows further longitudinal data analysis.
Completeness, validity, and further developments will depend on continued efforts of the GSTCVS in close collaboration with all cardiac surgical units in Germany. This will be of outstanding importance for the contribution to patient safety as well as to facilitate a high quality of cardiac surgery in Germany.